Deniger and colleagues demonstrated that the propagation of CD19+CD64+CD86+CD137L+IL-15+ APCs enhanced the activity of anti-CD19 CAR γδT cells against preclinical leukemia models in vivo [50]. The gene discussed is CD19; the disease is leukemia.